Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.55 USD | -3.79% | +6.61% | -38.37% |
01/05 | Journey Medical Corporation Appoints Joseph M. Benesch as Chief Financial Officer | CI |
21/03 | Transcript : Journey Medical Corporation, 2023 Earnings Call, Mar 21, 2024 |
Evolution of the average Target Price on Journey Medical Corporation
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Journey Medical Corporation
Alliance Global Partners | |
B. Riley | |
Cantor Fitzgerald | |
Roth Capital Partners |
EPS Revisions
- Stock Market
- Equities
- DERM Stock
- Consensus Journey Medical Corporation